Kiora Pharmaceuticals

Public

Kiora Pharmaceuticals is now publicly traded

The data on this page reflects Kiora Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Apr 21, 2026

Total Funding Raised

$20M

Company Overview

Kiora Pharmaceuticals is a clinical-stage biopharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases.

AI Layer

Non-AI

Keywords

small molecule therapyretinal disease therapyphotoswitchRetinitis PigmentosaRPmutation-agnostic therapyorphan retinal diseasevision restorationclinical stage biotechophthalmic drug developmentinherited retinal diseaseintravitreal injectionbiotech licensingpharma partnershipsuveitis treatmentStargardt diseaseChoroideremia

Kiora Pharmaceuticals Comparables

Compare Kiora Pharmaceuticals with similar companies based on industry and business-model similarity.

Kiora Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nanoscope Therapeutics Inc.	82%
Ray Therapeutics	79%
Restore Vision Inc.	76%

View all Comparables

Kiora Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Apr 21, 2026
Private Placement	Feb 14, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Brian M Strem

President, CEO And Director

Executive Team

Melissa Tosca

Chief Financial Officer

Executive Team

Kiora Pharmaceuticals Investors

Notable investors and investment history

Kiora Pharmaceuticals investors
Investor	Rounds
ADAR1 Capital Management	Private Placement
Velan Capital	Private Placement
Perceptive Advisors	Private Placement
Rosalind Advisors	Private Placement
Stonepine Capital Management	Private Placement
Nantahala Capital Management	Private Placement

View all Investors

Kiora Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kiora Pharmaceuticals Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersENCINITAS

Employee Range18

Year Founded1998

Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?